Sanjiu Group to return 1.1bln yuan before Sept.

According to foreign news reports, Sanjiu Pharmaceutical and its subsidiary are supposed to return 1.1 billion yuan to its listed vehicle before September 30, including 500 million in cash and 600 million in form of fixed assets. First majority shareholder of Sanjiu Biopharmaceutical has been censured by CSRC for misappropriating the listed companyˇ¦s assets up to 2.5 billion yuan.

Related stock : (NIL)